Go to Hepatitis B Foundation home page

Dr. Timothy Block: "What’s New on the HBV Drug Watch"

Dr. Timothy Block President, Hepatitis B Foundation and Professor, Drexel University College of Medicine. Dr. Timothy Block is the Co-Founder and volunteer President of the Hepatitis B Foundation and its research affiliate, the Institute for Hepatitis and Virus Research. He has been involved in viral hepatitis research for more than 20 years and is internationally recognized for his outstanding scholarship and scientific contributions. Dr. Block is a Professor of Microbiology and Immunology, Drexel University College of Medicine, and Director of the Drexel Institute for Biotechnology and Virology Research. At Oxford University, as a Sabbatical Fellow working with Dr. Baruch S. Blumberg (Nobel Laureate) and Prof. Raymond Dwek (Fellow, Royal Society), he discovered a plant sugar that has now received the trade name “glycovir” which is in preclinical studies for hepatitis B. Dr. Block is Chair, Gastroenterology Extramural Collaborative Groups of the cancer prevention section of the NCI; serves on several NIH study sections; elected Fellow, International Union Against Cancer; elected Fellow, Glycobiology Institute of the University of Oxford; and is the recipient of many awards and patents for his scientific achievements. This presentation available in AUDIO ONLY. Length 44 Minutes

1. What’s New on the HBV Drug Watch